Papers/PMID:27470399
Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2016The record
2 findings drawn from this paper, on 1 compound across 2 endpoints.
What it reported
How to read these marksWhat moved
2 findings
curcumin — decreases tumour necrosis factor alpha concentration
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Findingreplicated ×5“Between-group comparison suggested significantly greater reductions in serum concentrations of TNF-α, IL-6, TGF-β and MCP-1 in the curcumin versus placebo group (p<0.001).”
Quoted verbatim from Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- curcumin 1 g/day for 8 weeks
- Population
- adults with metabolic syndrome (NCEP-ATPIII criteria), post-hoc analysis
Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial.2016PMID:27470399
curcumin — decreases interleukin-6 concentration
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Findingreplicated ×5“Between-group comparison suggested significantly greater reductions in serum concentrations of TNF-α, IL-6, TGF-β and MCP-1 in the curcumin versus placebo group (p<0.001).”
Quoted verbatim from Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- curcumin 1 g/day for 8 weeks
- Population
- adults with metabolic syndrome (NCEP-ATPIII criteria), post-hoc analysis
Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial.2016PMID:27470399